HIL Applied Medical
Single room, ultra-compact proton beam systems for cancer therapy
HIL Applied Medical designs compact, cost-effective single-room solutions for high-performance cancer Proton Therapy (PT) systems. Their single-room PT solution is half the size, a third of the cost, and 1/100th the weight. These innovations hold the key to offering services to up to 95% of the demand for these treatments worldwide, making the most effective cancer treatments cheaper and more available to medical facilities and their patients around the world.
PT is the most advanced form of radiotherapy, the treatment most often used for fighting cancer. Nearly two out of three cancer patients receive some form of radiotherapy. Proton therapy is significantly safer and superior to traditional radiotherapy. PT reduces damage to healthy tissue by 2-6 fold, lowers the lifetime risk of secondary cancer by up to 97% in some cases, and improves patient survival rates and quality of life. PT has been used around the world for treating dozens of cancer types; it enjoys favorable reimbursement and has been FDA-cleared (510k) for over 25 years.
Unfortunately, there are only 97 PT facilities currently operating around the world, addressing only 3-5% of the clinical demand. Out of 3,000 PT rooms needed worldwide, there are only 181. This tremendous demand-supply gap is due to prohibitively expensive setup and operational costs associated with a typical PT center. The price tag and the large size of the current solutions (tennis-court sized rooms with equipment weighing up to 500 hundred tons) have so far stymied the adoption of PT to only the largest, deep-pocketed hospitals.
HIL aims to make PT affordable and practical to every midsize hospital/clinic, and thereby accessible to every patient. A complete treatment room based on HIL’s technology is estimated to cost $12-14M in comparison to the competitors’ $30-45M. HIL’s technology, first developed at the Hebrew University in Jerusalem, by founders Prof. Arie Zigler, Dr. Shmulik Eisenmann, is expected to reduce a treatment room size by over 50%, achieving a footprint similar to that of a standard radiotherapy vault.
Their patented approach to particle acceleration and beam delivery combines nano-technology with high-intensity lasers and advanced magnetics. PT utilizes a focused beam of high-energy protons beam to treat solid tumors anywhere in the body. Similar to traditional radiotherapy (X-Ray / Gamma), PT is completely non-invasive and pain-free.
With over three-dozen patents, a strategic investment from market leader IBA (and a co-commercialization agreement), a strategic partnership with industry giant THALES, and hospitals already lining up to become paying beta sites – HIL is gearing up for its next financing round to make their dream of accessible and affordable cancer treatment for all a reality.